# Perpetua Resources Corp.: financial statements, quarterly

PPTA · Nasdaq · CIK 1526243 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ppta.md) · [Financials](/companies/ppta/financials.md) · [Filings](/companies/ppta/filings.md) · [Insiders](/companies/ppta/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ppta/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(9.6)](/filings/0001104659-24-117760.md) | [(10.7) d](/filings/0001410578-25-000385.md) | [(8.1)](/filings/0001410578-25-001172.md) | [(12.2)](/filings/0001410578-25-001747.md) | [(16.5)](/filings/0001104659-25-112609.md) | [(15.3) d](/filings/0001104659-26-037403.md) | [(15.0)](/filings/0001104659-26-058253.md) | [(11.7)](/filings/0001104659-26-097134.md) | [(33.7)](/filings/0001104659-25-112609.md) | [(67.5) d](/filings/0001104659-26-037403.md) | [(56.6)](/filings/0001104659-26-058253.md) | [(107)](/filings/0001104659-26-097134.md) |
| Income tax | $m | [0.0 d](/filings/0001104659-23-116320.md) | [0.0 d](/filings/0001410578-25-000385.md) | [0.0](/filings/0001104659-24-059943.md) | [0.0 d](/filings/0001104659-24-087827.md) | [0.0 d](/filings/0001104659-24-117760.md) | [0.0 d](/filings/0001104659-26-037403.md) | [0.0](/filings/0001410578-25-001172.md) | [0.0 d](/filings/0001410578-25-001747.md) | [0.0 d](/filings/0001104659-25-112609.md) | [0.0 d](/filings/0001104659-26-037403.md) | [0.0](/filings/0001104659-26-058253.md) | [0.0 d](/filings/0001104659-26-097134.md) |
| Net income | $m | [(2.6)](/filings/0001104659-24-117760.md) | [(3.9) d](/filings/0001410578-25-000385.md) | [(2.9)](/filings/0001104659-25-112609.md) | [(3.7)](/filings/0001104659-25-112609.md) | [(3.6)](/filings/0001104659-25-112609.md) | [(4.3) d](/filings/0001104659-26-037403.md) | [(8.2)](/filings/0001104659-26-097134.md) | [(6.0)](/filings/0001104659-26-097134.md) | [(25.8)](/filings/0001104659-25-112609.md) | [(60.4) d](/filings/0001104659-26-037403.md) | [(48.6)](/filings/0001104659-26-097134.md) | [(97.5)](/filings/0001104659-26-097134.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001104659-24-117760.md) | not reported | [(0.05)](/filings/0001410578-25-001172.md) | [(0.06)](/filings/0001410578-25-001747.md) | [(0.05)](/filings/0001104659-25-112609.md) | not reported | [(0.12)](/filings/0001104659-26-058253.md) | [(0.08)](/filings/0001104659-26-097134.md) | [(0.24)](/filings/0001104659-25-112609.md) | not reported | [(0.39)](/filings/0001104659-26-058253.md) | [(0.78)](/filings/0001104659-26-097134.md) |
| Basic EPS | $ per share | [0.04](/filings/0001104659-24-117760.md) | not reported | [(0.05)](/filings/0001410578-25-001172.md) | [(0.06)](/filings/0001410578-25-001747.md) | [(0.05)](/filings/0001104659-25-112609.md) | not reported | [(0.12)](/filings/0001104659-26-058253.md) | [(0.08)](/filings/0001104659-26-097134.md) | [(0.24)](/filings/0001104659-25-112609.md) | not reported | [(0.39)](/filings/0001104659-26-058253.md) | [(0.78)](/filings/0001104659-26-097134.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.1](/filings/0001104659-24-117760.md) | [3.2](/filings/0001410578-25-000385.md) | [8.0](/filings/0001104659-24-059943.md) | [1.9](/filings/0001104659-24-087827.md) | [11.2](/filings/0001104659-24-117760.md) | [44.1](/filings/0001104659-26-037403.md) | [19.1](/filings/0001104659-26-058253.md) | [425](/filings/0001104659-26-097134.md) | [446](/filings/0001104659-25-112609.md) | [714](/filings/0001104659-26-097134.md) | [670](/filings/0001104659-26-058253.md) | [574](/filings/0001104659-26-097134.md) |
| Current assets | $m | [10.4](/filings/0001104659-23-116320.md) | [6.9](/filings/0001410578-25-000385.md) | [10.4](/filings/0001104659-24-059943.md) | [10.2](/filings/0001104659-24-087827.md) | [21.0](/filings/0001104659-24-117760.md) | [47.4](/filings/0001104659-26-037403.md) | [41.3](/filings/0001410578-25-001172.md) | [447](/filings/0001410578-25-001747.md) | [460](/filings/0001104659-25-112609.md) | [749](/filings/0001104659-26-097134.md) | [699](/filings/0001104659-26-058253.md) | [599](/filings/0001104659-26-097134.md) |
| Total assets | $m | [86.7](/filings/0001104659-23-116320.md) | [83.1](/filings/0001410578-25-000385.md) | [78.3](/filings/0001104659-24-059943.md) | [78.3](/filings/0001104659-24-087827.md) | [89.3](/filings/0001104659-24-117760.md) | [118](/filings/0001104659-26-037403.md) | [111](/filings/0001410578-25-001172.md) | [518](/filings/0001410578-25-001747.md) | [545](/filings/0001104659-25-112609.md) | [878](/filings/0001104659-26-097134.md) | [855](/filings/0001104659-26-058253.md) | [774](/filings/0001104659-26-097134.md) |
| Current liabilities | $m | [8.4](/filings/0001104659-23-116320.md) | [7.8](/filings/0001410578-25-000385.md) | [5.0](/filings/0001104659-24-059943.md) | [6.7](/filings/0001104659-24-087827.md) | [9.1](/filings/0001104659-24-117760.md) | [6.8](/filings/0001104659-26-037403.md) | [6.9](/filings/0001410578-25-001172.md) | [6.3](/filings/0001410578-25-001747.md) | [10.9](/filings/0001104659-25-112609.md) | [14.7](/filings/0001104659-26-097134.md) | [34.2](/filings/0001104659-26-058253.md) | [48.6](/filings/0001104659-26-097134.md) |
| Total liabilities | $m | [13.3](/filings/0001104659-23-116320.md) | [10.8](/filings/0001410578-25-000385.md) | [8.0](/filings/0001104659-24-059943.md) | [9.7](/filings/0001104659-24-087827.md) | [12.1](/filings/0001104659-24-117760.md) | [8.8](/filings/0001104659-26-037403.md) | [8.9](/filings/0001410578-25-001172.md) | [8.3](/filings/0001410578-25-001747.md) | [12.9](/filings/0001104659-25-112609.md) | [16.3](/filings/0001104659-26-097134.md) | [38.5](/filings/0001104659-26-058253.md) | [53.7](/filings/0001104659-26-097134.md) |
| Shareholders' equity | $m | [73.3](/filings/0001104659-24-117760.md) | [72.3](/filings/0001104659-26-037403.md) | [70.4](/filings/0001104659-25-112609.md) | [68.6](/filings/0001104659-25-112609.md) | [77.2](/filings/0001104659-25-112609.md) | [109](/filings/0001104659-26-097134.md) | [103](/filings/0001104659-26-097134.md) | [510](/filings/0001104659-26-097134.md) | [532](/filings/0001104659-25-112609.md) | [861](/filings/0001104659-26-097134.md) | [816](/filings/0001104659-26-097134.md) | [720](/filings/0001104659-26-097134.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.7) d](/filings/0001104659-24-117760.md) | [(5.9) d](/filings/0001410578-25-000385.md) | [(3.5)](/filings/0001410578-25-001172.md) | [(7.0) d](/filings/0001410578-25-001747.md) | [(1.3) d](/filings/0001104659-25-112609.md) | [(0.1) d](/filings/0001104659-26-037403.md) | [(25.6)](/filings/0001104659-26-058253.md) | [(6.6) d](/filings/0001104659-26-097134.md) | [(12.1) d](/filings/0001104659-25-112609.md) | [(60.3) d](/filings/0001104659-26-037403.md) | [(27.0)](/filings/0001104659-26-058253.md) | [(80.9) d](/filings/0001104659-26-097134.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0001104659-24-117760.md) | [(0.0) d](/filings/0001410578-25-000385.md) | [0.0](/filings/0001410578-25-001172.md) | [0.2 d](/filings/0001410578-25-001747.md) | [0.0 d](/filings/0001104659-25-112609.md) | [(0.0) d](/filings/0001104659-26-037403.md) | not reported | not reported | [0.3 d](/filings/0001104659-25-112609.md) | [0.0 d](/filings/0001104659-26-037403.md) | [19.4](/filings/0001104659-26-058253.md) | [12.9 d](/filings/0001104659-26-097134.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.0](/filings/0001104659-23-116320.md) | [63.0](/filings/0001104659-24-059943.md) | [63.2](/filings/0001104659-24-087827.md) | [63.2](/filings/0001104659-24-117760.md) | [64.1](/filings/0001410578-25-001172.md) | [64.5](/filings/0001410578-25-001747.md) | [65.5](/filings/0001104659-25-112609.md) | [70.6](/filings/0001104659-26-058253.md) | [76.5](/filings/0001104659-26-097134.md) | [107](/filings/0001104659-25-112609.md) | [125](/filings/0001104659-26-058253.md) | [125](/filings/0001104659-26-097134.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 125,095,803 at 2026-08-05, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-097134.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.